Product image of Omnadren 250 (Testosterone Decanoate, Testosterone Isocaproate, Testosterone Phenylpropionate, Testosterone Propio) supplied by GNH India

Omnadren 250

Active Ingredient:
Testosterone Decanoate, Testosterone Isocaproate, Testosterone Phenylpropionate, Testosterone Propio
Origin:
EU

Omnadren 250 (Testosterone Decanoate, Testosterone Isocaproate, Testosterone Phenylpropionate, Testosterone Propio)

Testosterone, the active ingredient in Omnadren 250, the active ingredient in Omnadren 250, is a androgenic anabolic steroid presented as a 250 mg/ml oil solution for intramuscular injection use. It is used to treat testosterone deficiency in males and certain hormone‑responsive conditions.

GNH India supplies Omnadren 250 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Bausch Health Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Omnadren 250 is a mixed testosterone ester preparation that acts on conditions related to androgen deficiency.

  • Male hypogonadism: restores normal serum testosterone levels and alleviates related symptoms.
  • Delayed puberty in adolescent males: supports the development of secondary sexual characteristics.
  • Hormone‑dependent breast cancer adjunct therapy: provides androgenic activity that can counter‑act estrogen‑driven tumor growth.
  • Male infertility associated with low testosterone: may improve spermatogenesis when combined with other therapies.
  • Catabolic states such as severe burns or chronic illness: assists in preserving lean body mass and supporting recovery.

How It Works

  • Omnadren 250 delivers four testosterone esters (decanoate, isocaproate, phenylpropionate and propionate) that are hydrolyzed after intramuscular injection, releasing testosterone gradually. The liberated testosterone binds to intracellular androgen receptors, modulating gene transcription that promotes protein synthesis, erythropoiesis and the development of male secondary sexual characteristics.

Side Effects

Adverse reactions to Omnadren 250 can vary with dose, duration of therapy and individual susceptibility.

Common Side Effects

  • Acne and oily skin: increased sebum production.
  • Fluid retention: mild peripheral edema.
  • Mood changes: irritability or heightened aggression.
  • Elevated red blood cell count: polycythemia risk.
  • Decreased HDL cholesterol: unfavorable lipid profile shift.

Serious or Rare Side Effects

  • Hepatotoxicity: liver enzyme elevation.
  • Cardiovascular events: thromboembolic disease.
  • Prostate enlargement: urinary obstruction risk.
  • Gynecomastia: breast tissue growth in males.
  • Severe allergic reaction: anaphylaxis or injection‑site anaphylaxis.

Precautions & Warnings

When prescribing Omnadren 250, clinicians should evaluate patient history and monitor relevant parameters.

  • Cardiovascular assessment: screen for hypertension, thromboembolic risk and lipid abnormalities.
  • Hepatic function: baseline liver enzymes and periodic monitoring.
  • Prostate health: assess for benign prostatic hyperplasia or cancer before initiating therapy.
  • Hematocrit monitoring: watch for polycythemia, especially in smokers.
  • Contraindications review: avoid in patients with known hypersensitivity to testosterone esters.
  • Store at below 25°C: keep in the original container, protect from light and moisture.

Avoid Interactions

Omnadren 250 may interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased risk of thrombosis.
  • 5‑α‑reductase inhibitors (finasteride, dutasteride): altered androgen metabolism.
  • Corticosteroids: additive fluid‑retention effects.

Moderate Interactions (Monitor Closely)

  • Insulin and oral hypoglycemics: testosterone can affect glucose tolerance.
  • Lipid‑lowering agents (statins): potential impact on lipid profile changes.
  • Thyroid hormones: possible influence on metabolic rate and hormone balance.

Frequently Asked Questions

Omnadren 250 is a mixed‑ester testosterone preparation used primarily to treat male hypogonadism, support delayed puberty in adolescent boys, and serve as an adjunct in certain hormone‑dependent conditions where androgen supplementation is indicated.

The four testosterone esters in Omnadren 250 are hydrolyzed after intramuscular injection, releasing testosterone that binds to intracellular androgen receptors. This activates gene transcription that promotes protein synthesis, erythropoiesis and the development of male secondary sexual characteristics.

The dosing regimen for Omnadren 250 is individualized; the prescribing clinician determines the dose, frequency and duration based on the patient’s condition, testosterone levels and response to therapy.

Omnadren 250 is contraindicated for use in pregnant or breastfeeding individuals. Testosterone can cross the placenta and be secreted in breast milk, potentially causing fetal or neonatal androgenic effects.

To order, submit an enquiry on the Omnadren 250 product page at gnhindia.com, providing the required quantity and institutional credentials. GNH India’s team will verify eligibility, then respond with pricing, availability, shipping details and any necessary import documentation.

Omnadren 250 combines four testosterone esters, offering a broader release profile than single‑ester products such as testosterone enanthate. This can reduce injection frequency but may also influence the pattern of serum testosterone peaks and troughs compared with other formulations.

Store Omnadren 250 at temperatures below 25 °C, in the original packaging, protected from light and moisture to maintain ester stability and potency.

Omnadren 250 is supplied as an oil‑based solution for intramuscular injection. It should be administered by a qualified healthcare professional using aseptic technique, typically into the gluteal muscle.

Serious risks include hepatotoxicity, cardiovascular events such as thrombosis, prostate enlargement leading to urinary obstruction, and rare allergic reactions. Patients should be monitored regularly for these adverse outcomes.

Individuals with known hypersensitivity to testosterone esters, active prostate cancer, uncontrolled cardiovascular disease, severe liver impairment, or those who are pregnant or breastfeeding should not use Omnadren 250.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Testosterone Decanoate, Testosterone Isocaproate, Testosterone Phenylpropionate, Testosterone Propio

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT